End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.22 CNY | -0.59% | +5.04% | -2.33% |
May. 02 | ICBC, CCB Name Deputy Party Secretaries | MT |
Apr. 12 | Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7% | MT |
Sales 2024 * | 6.12B 847M | Sales 2025 * | 7.3B 1.01B | Capitalization | 49.8B 6.89B |
---|---|---|---|---|---|
Net income 2024 * | 1.35B 187M | Net income 2025 * | 1.63B 226M | EV / Sales 2024 * | 8.14 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.82 x |
P/E ratio 2024 * |
36.6
x | P/E ratio 2025 * |
30.2
x | Employees | 4,858 |
Yield 2024 * |
0.5% | Yield 2025 * |
0.74% | Free-Float | 45.51% |
1 day | -0.59% | ||
1 week | +5.04% | ||
Current month | +5.04% | ||
1 month | +16.50% | ||
3 months | +2.44% | ||
6 months | +1.58% | ||
Current year | -2.33% |
Managers | Title | Age | Since |
---|---|---|---|
Dao Xing Fu
CEO | Chief Executive Officer | 60 | 17-04-24 |
Hui Chuan Yang
CHM | Chairman | 57 | 11-05-31 |
Bo Tian
IRC | Investor Relations Contact | - | 06-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yan Fang
BRD | Director/Board Member | 56 | 20-06-22 |
Hui Chuan Yang
CHM | Chairman | 57 | 11-05-31 |
Fen Ling Gu
BRD | Director/Board Member | 61 | 20-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.66% | 0 M€ | -12.22% | - | |
0.61% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 30.22 | -0.59% | 7,317,450 |
24-05-09 | 30.4 | +1.30% | 8,045,271 |
24-05-08 | 30.01 | +0.33% | 11,610,000 |
24-05-07 | 29.91 | +1.08% | 13,293,270 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.33% | 6.89B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 600161 Stock